A universal influenza vaccine – how does it work?

The study aims to investigate the safety, immunogenicity, and potential efficacy of OVX836 at different doses . Vaccine demonstrated an observed protection level of 84%, which was further corroborated by a pooled analysis . The findings are particularly encouraging, as they approach the target efficacy for a universal influenza vaccine (>75%)

TWiV 1033: Freediving with nanobodies and interferon

TWiV notes the passing of Harald zur Hausen, dengue breaking records in the Americas, inhibition of SARS-CoV-2 infection and inflammation by modulation of type I IFN, and an armed nanobody that protects mice against influenza A and B disease. Hosts: Vincent Racaniello, Kathy Spindler, and Angela Mingarelli Click arrow to playDownload TWiV 1033 (76 MB .mp3,… Continue reading TWiV 1033: Freediving with nanobodies and interferon

Co-evolution of immunity and seasonal influenza viruses

Abstract Seasonal influenza viruses cause recurring global epidemics by continually evolving to escape host immunity. The viral constraints and host immune responses that limit and drive the evolution of these viruses are increasingly well understood. However, it remains unclear how most of these advances improve the capacity to reduce the impact of seasonal influenza viruses… Continue reading Co-evolution of immunity and seasonal influenza viruses

Detection of human adenoviruses in influenza-negative patients with respiratory tract infections in Nanning, China

HAdV is associated with various clinical manifestations, including hepatitis,gastroenteritis, meningitis, cystitis, conjunctivitis, upper and lower respiratory tract infections, and myocarditis etc. [14,15,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Chhabra P, Payne DC, Szilagyi PG et al. Etiology of viral gastroenteritis in children 16,17,18,19,20]. Moreover, HAdV infection spreads easily, is highly contagious in some cases, can cause… Continue reading Detection of human adenoviruses in influenza-negative patients with respiratory tract infections in Nanning, China